Insmed initiated with an Outperform at BMO Capital
Very bullish setup
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Very bullish setup
What happened, with direct paths to the underlying reporting
BMO Capital initiated coverage with Outperform; target price $192; current price $107.02.
Target: $192
Posted price: $107.02
Analyst firm: BMO Capital
Analyst: Conor MacKay
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.